Chemclin Diagnostics released its semi-annual performance, with a net profit attributable to the parent company of 24.34 million yuan, a year-on-year decrease of 68.24%

Zhitong
2025.08.29 11:56
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, Chemclin Diagnostics disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 165 million yuan, a year-on-year decrease of 27.03%; net profit attributable to the parent company was 24.34 million yuan, a year-on-year decrease of 68.24%; net profit excluding non-recurring gains and losses was 15.92 million yuan, a year-on-year decrease of 77.35%; basic earnings per share were 0.06 yuan

According to the Zhitong Finance APP, Chemclin Diagnostics (688468.SH) disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 165 million yuan, a year-on-year decrease of 27.03%; net profit attributable to the parent company was 24.34 million yuan, a year-on-year decrease of 68.24%; net profit excluding non-recurring gains and losses was 15.92 million yuan, a year-on-year decrease of 77.35%; basic earnings per share were 0.06 yuan

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.